Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_4

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

Phase 4Post-market surveillance

1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Other(1)

Detailed Status

Completed4

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

unknown117%

completed467%

terminated117%

Recent Activity

0 active trials

Showing 5 of 6

terminated

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

NCT02549638

completed

Pangenomic Study During Alcoholic Cirrhosis

NCT01065233

completed

Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)

NCT03627780

completed

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

NCT04561895

unknown

Gut Microbiota Metagenomics for Chronic Liver Disease

NCT04339725

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT02549638

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

Terminated

NCT01065233

Pangenomic Study During Alcoholic Cirrhosis

Completed

NCT03627780

Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)

Completed

NCT04561895

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

Completed

NCT04339725

Gut Microbiota Metagenomics for Chronic Liver Disease

Unknown

NCT02977208Phase 4

Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use

Completed

All 6 trials loaded

Drug Details

Intervention Type: GENETIC
Total Trials: 6